| Ministry/Division |
: |
Ministry of Health and Family Welfare |
| Agency |
: |
Essential Drugs Company Limited (EDCL)
|
| Procuring Entity Name |
: |
Managing Director |
| Procuring Entity Code |
: |
N/A |
| Procuring Entity District |
: |
Dhaka |
| Expression of Interest for Selection of |
: |
Consulting Firm (National) (Lump-Sump) |
| Title Of Service |
: |
Bioequivalence (BE) Study of Oral Contraceptive Pill for Sukhi Tablet, 3rd generation (Desogestrel USP 150 µg & Ethinyol Estradiol USP 30 ug) |
| EOI Ref. No. |
: |
EDCL/Dhaka/EOI/Consultant/2025/211 |
| Date |
: |
15/10/2025 |
KEY INFORMATION
|
| Procurement Sub-Method |
: |
Quality and Cost Based Selection(QCBS) |
FUNDING INFORMATION
|
| Budget and Source of Funds |
: |
Own Funds Own Funds |
| Development Partners |
: |
- |
PARTICULAR INFORMATION
|
| Project/Programme Name |
: |
Bioequivalence (BE) Study of Oral Contraceptive Pill for Sukhi Tablet, 3rd generation (Desogestrel USP 150 µg & Ethinyol Estradiol USP 30 ug) |
| EOI Closing Date and Time |
: |
06/11/2025 3:00 pm (BST)
|
| Publication Date |
: |
19/10/2025
|
INFORMATION FOR APPLICANT
|
| Brief Description of Assignment |
: |
Bioequivalence (BE) Study of Oral Contraceptive Pill for Sukhi Tablet, 3rd generation (Desogestrel USP 150 ug & Ethinyol Estradiol USP 30 ug) |
| Experience, Resources and Delivery Capacity Required |
: |
1) At least 2 complete BE studies on hormonal contraceptives (or similar sex-
hormone products) in the last 5 years, if none, at least 5 completed BE studies for other hormones with female volunteer experience.
2) CRO must have Bio analytical capability must own or contracted lab). 3) CRO must have GCP/GLP/ISO certified clinical unit and a Volunteer
management system.
4) CRO must have accredited from any national or international regulatory body (WHO prequalified or recognized regulatory approvals i,e, USFDA, EMA, MHRA, TGA etc.) |
| Other Details (if applicable) |
: |
Expression of Interest will include brochures with a list of key professionals and their experience in similar working conditions, logistics, expertise, and relevant documents for similar assignments, along with resource availability. Copies of the documents establishing the constitution or legal status, registration place, and main place of business; a written power of attorney from the signatory of the EOI authorizing the CRO to act; a Bank Solvency Certificate accompanied by bank statements from the last three years. A list of similar service experience records, including the employer's name, service location, scope, contract value, start and end dates, as well completions certificate. Consulting Firm should sign and stamp the all pages of TOR and submit the same along with EOI.
Marked "Request for Expression of Interest (EOI) for Selection of CRO for Bioequivalence (BE) Study of Oral Contraceptive Pill" and delivered to the address mentioned herewith prior to the closing of EOI. |
| Association with foreign firms is |
: |
Encouraged |
| Eoi Detail Information |
|---|
| Ref No |
Phasing Of Services |
Location |
Start Date |
Completion Date |
| 1 |
Bioequivalence (BE) Study of Oral Contraceptive Pill for Sukhi Tablet, 3rd generation (Desogestrel USP 150 ug & Ethinyol Estradiol USP 30 ug) |
395-397, Tejgaon Industrial Area, Dhaka-1208, Bangladesh. |
- |
- |
|
PROCURING ENTITY DETAILS
|
| Name of Official Inviting EOI |
: |
Engr. Mir Md. Shahabuddin |
| Designation of Official Inviting EOI |
: |
Dy. General Manager, Procurement (CC) Essential Drugs Company Limited |
| Address of Official Inviting EOI |
: |
395-397, Tejgaon Industrial Area, Dhaka-1208, Bangladesh.
|
| Contact details of Official Inviting EOI |
: |
Phone : 8151080, Fax : , Email : gmprocurementedcl2020@gmail.com |
| The procuring entity reserves the right to accept or reject all tenders |
